T1	p 151 190	adjuvant chemotherapy for breast cancer
T2	p 507 520	breast cancer
T3	p 827 873	chemotherapy-na?ve patients with breast cancer
T4	p 1117 1165	age of the 94 women was 51 years ( range 27-76 )
T5	i 115 128	dexamethasone
T6	i 364 377	dexamethasone
T7	i 543 556	dexamethasone
T8	i 560 567	placebo
T9	i 762 775	dexamethasone
T10	i 815 822	placebo
T11	i 910 921	granisetron
T12	i 926 939	dexamethasone
T13	i 966 977	granisetron
T14	i 1180 1220	fluorouracil/epirubicin/cyclophosphamide
T15	i 1237 1265	doxorubicin/cyclophosphamide
T16	i 1384 1391	placebo
T17	i 1467 1480	dexamethasone
T18	i 1676 1689	dexamethasone
T19	i 1862 1875	dexamethasone
T20	i 1879 1886	placebo
T21	o 85 100	quality of life
T22	o 637 660	quality of life ( QOL )
T23	o 1020 1038	patient preference
T24	o 1077 1090	change of QOL
T25	o 1535 1596	intensity of vomiting , nausea , or time to onset of vomiting
T26	o 1629 1639	global QOL
T27	o 1695 1700	other
T28	o 1801 1839	patient preference , QOL , or symptoms